These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25726033)

  • 21. Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population.
    Berra C; De Fazio F; Azzolini E; Albini M; Zangrandi F; Mirani M; Garbossa S; Guardado-Mendoza R; Condorelli G; Folli F
    Acta Diabetol; 2019 Aug; 56(8):931-938. PubMed ID: 30929079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals.
    Yue X; Wu J; Ruan Z; Wolden ML; Li L; Lin Y
    Value Health Reg Issues; 2020 May; 21():17-21. PubMed ID: 31634792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
    Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
    J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.
    Ganz ML; Li Q; Wintfeld NS; Lee YC; Sorli C; Huang JC
    Curr Med Res Opin; 2015; 31(9):1809-15. PubMed ID: 26196226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Falling Again? Falls in Geriatric Adults-Risk Factors and Outcomes Associated With Recidivism.
    Prabhakaran K; Gogna S; Pee S; Samson DJ; Con J; Latifi R
    J Surg Res; 2020 Mar; 247():66-76. PubMed ID: 31767279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic burden of hypoglycemia for type II diabetes mellitus patients in Malaysia.
    Aljunid SM; Aung YN; Ismail A; Abdul Rashid SAZ; Nur AM; Cheah J; Matzen P
    PLoS One; 2019; 14(10):e0211248. PubMed ID: 31652253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and Trends in Hypoglycemia Hospitalization in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study.
    Zhong VW; Juhaeri J; Cole SR; Kontopantelis E; Shay CM; Gordon-Larsen P; Mayer-Davis EJ
    Diabetes Care; 2017 Dec; 40(12):1651-1660. PubMed ID: 28716781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors associated with falls in elderly patients with type 2 diabetes.
    Chiba Y; Kimbara Y; Kodera R; Tsuboi Y; Sato K; Tamura Y; Mori S; Ito H; Araki A
    J Diabetes Complications; 2015; 29(7):898-902. PubMed ID: 26122285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus.
    Kent DJ; McMahill-Walraven CN; Panozzo CA; Pawloski PA; Haynes K; Marshall J; Brown J; Eichelberger B; Lockhart CM
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1162-1171. PubMed ID: 31405345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accidents in patients with insulin-treated diabetes: increased risk of low-impact falls but not motor vehicle crashes--a prospective register-based study.
    Kennedy RL; Henry J; Chapman AJ; Nayar R; Grant P; Morris AD
    J Trauma; 2002 Apr; 52(4):660-6. PubMed ID: 11956379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: A population-based nested case-control study.
    Lai JH; Wang MT; Wu CC; Huang YL; Lu CH; Liou JT
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):842-853. PubMed ID: 32483856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland.
    Brändle M; Azoulay M; Greiner RA
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):217-30. PubMed ID: 21329624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy.
    Raju A; Shetty S; Cai B; D'Souza AO
    J Manag Care Spec Pharm; 2016 May; 22(5):483-92. PubMed ID: 27123911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes.
    Levin PA; Zhou S; Gill J; Wei W
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1172-81. PubMed ID: 26679966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population.
    Meng J; Casciano R; Lee YC; Stern L; Gultyaev D; Tong L; Kitio-Dschassi B
    J Manag Care Spec Pharm; 2017 Apr; 23(4):446-452. PubMed ID: 28345434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.
    Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL
    J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States.
    Ganz ML; Wintfeld NS; Li Q; Lee YC; Gatt E; Huang JC
    Curr Med Res Opin; 2014 Oct; 30(10):1991-2000. PubMed ID: 24945720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study.
    Yun JS; Park YM; Han K; Cha SA; Ahn YB; Ko SH
    Cardiovasc Diabetol; 2019 Aug; 18(1):103. PubMed ID: 31412855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization.
    Dalal MR; Kazemi M; Ye F; Xie L
    Adv Ther; 2017 Sep; 34(9):2083-2092. PubMed ID: 28779282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes.
    Rajpathak SN; Fu C; Brodovicz KG; Engel SS; Lapane K
    Drugs Aging; 2015 Apr; 32(4):321-7. PubMed ID: 25825122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.